EOEddison Igho Oghonyon

Eddison Igho Oghonyon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eddison Igho Oghonyon has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Larvicidal Efficacy of Plant-Mediated Silver Nanoparticles from Gmelina arborea and Hyptis suaveolens Against Wild Anopheles Vectors

    by Merylann Ochieng, Sandra Okoye, Eddison Oghonyon, Oluwatosin Idowu

    Malaria remains a leading cause of morbidity and mortality in sub-Saharan Africa, with escalating insecticide resistance among Anopheles vectors threatening the sustainability of current control interventions. The search for novel, environmentally benign larvicidal agents has increasingly focused on nanotechnology innovations derived from medicinal plants. This study assessed the larvicidal potential of silver nanoparticles (AgNPs) synthesized using aqueous leaf extracts of Gmelina arborea and Hyptis suaveolens against wild Anopheles larvae collected from Lagos State, Nigeria. Fresh plant samples were authenticated botanically, and green synthesis of AgNPs was confirmed by a characteristic honey-brown colour change and UV–visible spectrophotometric analysis. Larvicidal bioassays were performed according to WHO guidelines using six graded concentrations under controlled insectary conditions. Mortality was recorded at 24, 48, and 72 hours, and toxicological responses were analyzed using probit regression in IBM SPSS v20. After 72 hours, both AgNP formulations demonstrated a concentration-dependent increase in larval mortality, with H. suaveolens AgNPs showing greater bioefficacy than G. arborea AgNPs. Specifically, H. suaveolens AgNPs achieved LC₅₀ and LC₉₅ values of 0.292 ppm and 1.948 ppm respectively, whereas LC₅₀ = 0.469 ppm and LC₉₅ = 3.919 ppm were recorded for G. arborea AgNPs. Control mortality remained ≤10%, validating experimental reliability. The potent larvicidal activity displayed by both plant-derived AgNPs suggests that phytochemical-mediated nanoparticle synthesis may enhance toxicity against mosquito vectors while retaining environmental safety. These findings provide evidence supporting the integration of green nanotechnology into vector-control strategies to help mitigate resistance to conventional insecticides and strengthen malaria prevention efforts in endemic communities.

  • Open Access

    Gut Microbiome Dynamics and Their Emerging Role in Breast and Colorectal Cancer: Implications for Diagnosis and Therapy

    by Chukwunwejim C. R., Nzube F. Ekpunobi, Eddison Igho Oghonyon, Nwasoluchukwu Obidi, Kingsley C. Agu

    The gut microbiome, a complex community of microorganisms residing in the gastrointestinal tract, is increasingly recognized as a critical player in cancer pathophysiology. Its influence extends beyond local gastrointestinal disorders to systemic diseases, including breast and colorectal cancers. This review examines current evidence on the interplay between gut microbial dysbiosis and the development, progression, and treatment response in both malignancies. In colorectal cancer (CRC), pathogenic bacteria such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis have been implicated in tumor initiation and progression through mechanisms involving chronic inflammation, DNA damage, and immune modulation. Meanwhile, in breast cancer, the gut microbiome may contribute indirectly via regulation of estrogen metabolism, immune signaling, and systemic inflammation. Furthermore, the gut microbiota is increasingly being explored as a source of non-invasive biomarkers for early detection and disease monitoring, as well as a modifiable factor that could enhance therapeutic efficacy. Interventions such as probiotics, prebiotics, dietary modulation, and fecal microbiota transplantation (FMT) hold promise in reprogramming the microbiome to support antitumor responses and reduce treatment-related toxicity. Despite the growing body of research, translating these findings into clinical application requires deeper mechanistic understanding and standardized methodologies. This review emphasizes the need for longitudinal and multi-omics studies to unravel causal relationships and identify therapeutic targets. Understanding gut microbiome dynamics offers exciting opportunities for developing microbiota-informed strategies for cancer prevention, diagnosis, and therapy—particularly in breast and colorectal cancers.

  • Open Access

    Prevalence, Molecular Characterization and Antibiogram Susceptibility Pattern of Clostridioides difficile from Food Samples in South Eastern Nigeria

    by Eddison I. Oghonyon, Malachy C. Ugwu, Charles O. Esimone, Anthony I. Onah, Josiah E. Ifie

    Clostridioides difficile is a foodborne bacterium that causes severe gastrointestinal infections due to its virulence and antibiotic resistance. The major reason for this research is to ascertain Clostridioides difficile prevalence, molecular characterization, and antibiogram patterns in food samples from southeast Nigeria. A total of 440 food samples, including smoked fish and pork, were analyzed between June 2018 and December 2019. Enumeration of total anaerobes was performed using standard bacteriological techniques, while Clostridioides difficile isolation was carried out on selective differential agar. Biochemical identification was confirmed using molecular methods. The Kirby-Bauer disc diffusion was done to ascertain antibiogram susceptibility, and PCR activity was carried out to identify resistance gene (tetS, tetA, and ermB) and virulence (tcdA, tcdB, cdtA, and cdtB). Anaerobic bacterial counts varied across states, ranging from 1.85±0.12 log10 CFU/g in Enugu to 2.15±0.03 log10 CFU/g in Imo. Smoked fish and pork exhibited higher counts, with values between 5.16±0.01 and 5.36±0.01 log10 CFU/g. Identified anaerobes included Lysinibacillus macroides, Clostridium bolteae, Clostridium butyricum, and Clostridioides difficile. The prevalence of Clostridioides difficile was 2.00%, with isolates showing resistance to tetracycline (73.91%), erythromycin (73.91%), and ciprofloxacin (43.48%). Multiple antibiotic resistance was recorded at a rate of 0.44. Binary toxin genes (cdtA and cdtB) were found at low levels, 69.56% expressed tcdA, and all isolates of Clostridioides difficile carried the tcdB gene. Although rare in the area, binary toxin genes still pose a risk of severe Clostridioides difficile infections. This study emphasizes the significance of ongoing monitoring and controlling antibiotic resistance in foodborne bacteria.